Success Metrics

Clinical Success Rate

50.0%

Based on 3 completed trials

Completion Rate

50%(3/6)

Active Trials

1(13%)

Results Posted

33%(1 trials)

Terminated

3(38%)

Phase Distribution

Ph phase_2

13%

Ph phase_3

13%

Ph not_applicable

63%

Ph phase_4

13%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 2Efficacy & side effects

1(12.5%)

Phase 3Large-scale testing

1(12.5%)

Phase 4Post-market surveillance

1(12.5%)

N/ANon-phased studies

5(62.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

3 of 6 finished

Non-Completion Rate

50.0%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(3)

Terminated(3)

Detailed Status

Terminated3

Completed3

Recruiting1

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (12.5%)

Phase 31 (12.5%)

Phase 41 (12.5%)

N/A5 (62.5%)

Trials by Status

terminated338%

recruiting113%

completed338%

not_yet_recruiting113%

Recent Activity

1 active trials

Showing 5 of 8

completednot_applicable

Evaluation of an Organized Consultation "Return Home" of Patients With a Cancer (CREDO)

NCT02857400

recruitingphase_2

Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in Patients With Hepatocellular Carcinoma

NCT07302919

terminatedphase_3

Early High-Titre Convalescent Plasma in Clinically Vulnerable Individuals With Mild COVID-19

NCT05271929

terminatednot_applicable

Effectiveness of the EmoLED Medical Device in the Healing of Digital Ulcers in Patients With Scleroderma.

NCT05181644

completednot_applicable

Individualized Exercise Oncology Program for Newly Diagnosed Breast Cancer Patients

NCT04106609

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT02857400Not Applicable

Evaluation of an Organized Consultation "Return Home" of Patients With a Cancer (CREDO)

Completed

NCT07302919Phase 2

Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in Patients With Hepatocellular Carcinoma

Recruiting

NCT05271929Phase 3

Early High-Titre Convalescent Plasma in Clinically Vulnerable Individuals With Mild COVID-19

Terminated

NCT05181644Not Applicable

Effectiveness of the EmoLED Medical Device in the Healing of Digital Ulcers in Patients With Scleroderma.

Terminated

NCT04106609Not Applicable

Individualized Exercise Oncology Program for Newly Diagnosed Breast Cancer Patients

Completed

NCT06377046Not Applicable

Accelerated Pacing in Patients Undergoing Pace-and-ablate Strategy With LBBAP: a Randomized Controlled Pilot Trial

Not Yet Recruiting

NCT03872336Phase 4

Acute Labetalol Use in Preeclampsia

Terminated

NCT03199937Not Applicable

Executive Function Intervention for High School Students With ASD

Completed

All 8 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 8